Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Teva paid 40 billion for allergans generic business
View:
Post by fundtrader on Sep 16, 2016 3:13am

Teva paid 40 billion for allergans generic business

lots of money in generics..i guess cxr is worth close to 10 billion then or 80$ us a share
Comment by Craigbad on Oct 13, 2016 10:26pm
Comment by LaticelnExile on Oct 13, 2016 10:36pm
This post has been removed in accordance with Community Policy
Comment by Craigbad on Oct 13, 2016 10:40pm
In fairness he didn't say $80 per share, he said $80US per share! Lol I just hope he didn't scare any hard working, innocent shorts into covering.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities